Integrated Biologics Development

Catalent Biologics provides advanced technologies and tailored solutions for biologic development from DNA to commercial supply. Catalent recently commenced a $200-million investment to expand drug substance and drug-product manufacturing capacity at its Madison, WI and Bloomington, IN sites. The expansions were in response to increasing demand from existing and future customers following the company’s 30th commercial product approval.

Catalent
BIO Booth #3101